{"name":"YM BioSciences","slug":"ym-biosciences","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Respiratory","slug":"respiratory","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"AeroLEF","genericName":"AeroLEF","slug":"aerolef","indication":"Treatment of acute asthma exacerbations","status":"phase_2"}]}],"pipeline":[{"name":"AeroLEF","genericName":"AeroLEF","slug":"aerolef","phase":"phase_2","mechanism":"AeroLEF is a liposome-encapsulated formulation of budesonide, a corticosteroid that reduces inflammation.","indications":["Treatment of acute asthma exacerbations"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNVlJMRmk2cUY5emJIeVVsQ2x1bUFXQlcycS04UnJETFV6QlNSaW5WVzJmRXl5VFdFa3UwU2NtczByVnRhWGpGZnowYkhMRW9WRW1SaHV5MW9zWlp3THVOMC04cjhCRW5uUFg2cEJJRUFYNThVbmlJLWI0SXBsUTBiNkJHb0lGYzRkSXQzb2NudmxNampfTnVRc3lXNUE0U1RsNWJkbQ?oc=5","date":"2026-04-01","type":"pipeline","source":"Tracxn","summary":"List of 20 Acquisitions by Gilead (Apr 2026) - Tracxn","headline":"List of 20 Acquisitions by Gilead (Apr 2026)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQQWZyY3JqTWl5blJ4a25McVAxSGZwckkzZmxZVGlXX1FiZkw1QVRVZWVkbEsyb2lqTk5NRmh3alhvd3JjMVZkaHdVcVFZMUNsOUpKRGNzUnFxM1EwUld6TDMycXBOZFZYV1NyNjVpQnRBalpiTXJDQVdNMGZvb3ctcDdOUzJ0Ti1MT21fLVJINXQ5SEh5SEl3?oc=5","date":"2023-05-08","type":"pipeline","source":"BioSpace","summary":"Pharma’s Biggest Losses: Once-Dropped Drugs Make Lucrative Comebacks - BioSpace","headline":"Pharma’s Biggest Losses: Once-Dropped Drugs Make Lucrative Comebacks","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQZi1Scll5Q3lDcHluWnZCTjFoakJrQ1ptamMtYWx2akw2Tld0SXJfWWNrd3NPY0tzWk5MMVRZOVkxb2wwVk1TYURDLU50b05wWVlRTkxLSUg4UGsyLUlhcVMyT3pJRF9UTVZkWmd3VUlSYkNaR1ZQM0pieTRmaXduMVhic190QlA0UkNDaFZWR3FBU3V3?oc=5","date":"2022-04-13","type":"deal","source":"BioPharma Dive","summary":"GSK acquires Sierra Oncology, betting $2B on a bone cancer drug with a long history - BioPharma Dive","headline":"GSK acquires Sierra Oncology, betting $2B on a bone cancer drug with a long history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxNcmh0bVFNZW80dlJrcmtTQmlaenFUNlpIR0ZsOW9JRjFTZk9mYV9HazlXMXlqd2haRFRhanphNUFTT0lzWFhBQkNyTlA3c1FYeWZHcEtvcVRPTzhpc2tzbGU0dGZ3OHVsOXozZzRkWldDRWxiVVRrVWZXeDJqbm56MmdKNmZxNngwYnlDNDBfSEx3b2oxX2tmazRxZzNWem5wcVh0Qm9MQ1ZSQkxoM2htbmJlNWpsMDctbXNmN2Mwc1g2YXNwT3c?oc=5","date":"2021-08-05","type":"pipeline","source":"Fierce Biotech","summary":"Sierra raids the bargain bin again, picking up AstraZeneca cancer drug to pair with Gilead castoff - Fierce Biotech","headline":"Sierra raids the bargain bin again, picking up AstraZeneca cancer drug to pair with Gilead castoff","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxOeHVUZGcyQkxQQkVvdU5pVWR5aFdkVnYtQzUzYXdSUDYtcDVjaG83S0lKQmFpY2RENUhHc1labU02RG5TMWtMUF9id0s1UHRlY19mZ3FrVDlSQk94VUR2MmlmTFdNcWRLTDAyMmxhNnh0RFJCRUJhbnBoUHJoUlRHOVV5M3U?oc=5","date":"2020-08-27","type":"pipeline","source":"Global Venturing","summary":"BMS to fork over cash for Forbius - Global Venturing","headline":"BMS to fork over cash for Forbius","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE45UnpGUXBlT2NCN05OYTVrWDQtUHFXb3lrV29Lc0dYYUJnWm55WlBOVEN0Ml96cHIzV0phNEhDbEYwUnhoQ0E1OU9DaVVRR2h6U0MzT1VB?oc=5","date":"2018-07-03","type":"pipeline","source":"Nature","summary":"People - Nature","headline":"People","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNVVhkcWV4N3pTREhvTDIwSlFWdlVWRDBRZDlscjZwZWJ2Wm9sbzFBbl9OeDI4aHVvNjFCQTRPZTBieGxsR3B4WHNkUlEyYUVOM0xWM0MxeUJkbV9LcWdiLUttcGhNMlBCUmo0aHdObExlRlBoR2dFX0VwUUlGNk5ZbG5EZV9sYXpFMVdtTG9TMkd5ZEczWElxWXI0WnFOM3kxUldNRFJZbkM?oc=5","date":"2015-02-12","type":"pipeline","source":"Knowledge at Wharton","summary":"How Cuba’s Health Care Sector Aims to Gain a Greater Foothold - Knowledge at Wharton","headline":"How Cuba’s Health Care Sector Aims to Gain a Greater Foothold","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPczJXWVR5aEEweFFHREVZQ1BpNnBqN3l0cnhETG0zQWVWNUIyU3RYUTVfSlBqeVlpOWhSWkNOYkN0U2RGYzNUeFZ0dFVFMFg3UXUwNHBSdlQ5cEV3NWFGVE56RlZ4NkRGdHFYSGE1a3FXM19TVW5lUDBkOXZKcVR0WGJodVV1ek81MUZOSkdqelB5UXBmdGtNaXJrcFRBcTl6WTlR?oc=5","date":"2013-06-12","type":"earnings","source":"BioSpectrum Asia","summary":"What are the key mergers & acquisitions of Q1 2013? - BioSpectrum Asia","headline":"What are the key mergers & acquisitions of Q1 2013?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxOLTF0aW85LWRYTVVJa29ITkRDMmxweEtJbmJUbkZGR2J6NXBRdVdHVVFfejR5MHVrZVFsX0ZzcWdhWHlpdU1xNnNCYVhLdHc5QS00Vll1ajBOcUFGR0dKVGhQV3FkQWd5ZW1zaWRsNTIzaHRraXJNdkluSWJtWTR2YkgwbWNLa05WS2duSjdjM2toYW1rWTgycGRaejBlQWdfYXNEYmVoS3lhR1Yyb1RRN2tFbkFZbWV5VGhVX0hzRTNZRWNncWJNa1pwUQ?oc=5","date":"2013-06-11","type":"pipeline","source":"prnewswire.com","summary":"MEI Pharma Adds Former YM BioSciences CEO Nick Glover To Board Of Directors - prnewswire.com","headline":"MEI Pharma Adds Former YM BioSciences CEO Nick Glover To Board Of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE8tX0Flcl8xQk9FVkwxMTU5V0ktUDBBaE1XLUFZNzdlU0hfd3lvNVVoLXdpOGo1QmpkS1h0Y21LejRHMUZhbm41cm9VUmRWR25UTWtUcV9XdGk1emszWDdPMF9RUkNLaFJVNDZF?oc=5","date":"2013-01-08","type":"deal","source":"Genetic Engineering and Biotechnology News","summary":"Top 25 M&A Deals of 2012 - Genetic Engineering and Biotechnology News","headline":"Top 25 M&A Deals of 2012","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE5HamZlR3cyYVdsWXRrSTh3TWRGSklnS0VkZXpWWEx3S0Mtbm1JQzVSN0oxYi1GLVhrcnZvam5JVTVvWk9QZnNFLUlOaVdJaW9yVi1fcThtejJaVl9lTmVCWndVRTRfV0ZObTN5Y0NwNHg2ai1fODdV?oc=5","date":"2008-03-03","type":"pipeline","source":"Inquirer.com","summary":"On the Boards - Inquirer.com","headline":"On the Boards","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE5TVjhYbHdWSUJBVlNPTUxTZXdKbkdseHlRUWxyRUl1Q3BUeTVJeDlXOURwSW4zSUxpWW5LMEpRSFktQmZuMnVQWEY3MDlJeFBwM1FfbVAtXzNKUGxXQmNxWXc1THlBYXg4WTd3?oc=5","date":"2007-01-05","type":"trial","source":"Clinical Trials Arena","summary":"Tesmilifene – Chemopotentiator for Cancer - Clinical Trials Arena","headline":"Tesmilifene – Chemopotentiator for Cancer","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}